Oncotarget

Reviews:

Glioblastoma research: US and international networking achievements

David A. Groneberg _, Anna-Maria Addicks, Michael H. Bendels, David Quarcoo, Jenny Jaque and Dörthe Brüggmann

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:115730-115735. https://doi.org/10.18632/oncotarget.21270

Metrics: PDF 386 views  |   HTML 923 views  |   ?  


Abstract

David A. Groneberg1, Anna-Maria Addicks1, Michael H. Bendels1, David Quarcoo1, Jenny Jaque2 and Dörthe Brüggmann1,2

1Division of Epidemiology, Institute of Occupational Medicine, Social Medicine and Environmental Medicine, Goethe-University, Frankfurt, Germany

2Department of Obstetrics and Gynecology, Keck School of Medicine of USC, Los Angeles, CA, USA

Correspondence to:

David A. Groneberg, email: arbsozmed@uni-frankfurt.de

Keywords: glioblastoma, network, bibliometry, architecture, structure

Received: August 05, 2017     Accepted: September 03, 2017     Published: September 26, 2017

ABSTRACT

Being the most aggressive type of brain tumor, glioblastoma is estimated to be diagnosed in about 12,400 new cases in 2017. The diagnosis is dramatic to patients and relatives and leaves open many unanswered questions for them. One is the big question why there is no cure as in other tumors. This review illustrates the US and global research efforts that have been made over the past century. It demonstrates the great magnitude of energy invested by US clinicians and scientists but undoubtedly, more research is needed and funding by NIH and other sources should be continued on the same level.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 21270